-

Acadia Healthcare Names David Keys as Chief Development Officer

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that David M. Keys, CFA, has been named Chief Development Officer. Keys will focus on mergers & acquisitions, de novo development and expansion opportunities.

Keys has been active in the healthcare services market for nearly two decades, including more than 15 years in investment banking and mergers and acquisitions advisory work. Prior to joining Acadia, he covered behavioral health and several physician practice management sectors as a managing director for Truist Securities, Inc., which he joined following the merger of SunTrust and BB&T. Prior to the merger, Keys was a managing director and head of healthcare investment banking for BB&T Capital Markets after having previously launched the healthcare advisory group at a Richmond-based boutique investment bank. Earlier in his career, he was an investment banker at Harris Williams & Co. and Piper Jaffray.

In addition to advisory work within the substance use disorder, eating disorder and at-risk-youth sectors, Keys was a co-founder of Creswell Partners, where he and his partners established Averhealth, a leading provider of substance use disorder treatment monitoring, care management and related support services to individuals on behalf of criminal justice systems and judicial treatment programs.

Keys earned a bachelor's degree from the University of North Carolina and an MBA from the University of Chicago Booth School of Business.

“David Keys is a respected healthcare expert with extensive experience leading strategic growth programs across the entire healthcare spectrum,” said Debbie Osteen, Chief Executive Officer of Acadia Healthcare Company. “He brings unique talents to Acadia through his previous work in investment banking, advisory and development. As demand for our behavioral health services continues to increase, we will pursue best-in-class transactions and strategic partnerships to meet the needs of the communities we serve across the United States and Puerto Rico. We look forward to working together as we execute Acadia’s growth strategy.”

“I am thrilled to join Acadia at a time when increased recognition of the need for behavioral health services is directly leading to expansion opportunities,” said Keys. “Whether through strategic acquisitions, de novo openings or facility expansions, I am proud to join a team that is focused on providing high quality patient care while delivering results through both a growth- and returns-oriented framework.”

About Acadia

Acadia is a leading provider of behavioral healthcare services across the United States. As of June 30, 2021, Acadia operated a network of 229 behavioral healthcare facilities with approximately 10,100 beds in 40 states and Puerto Rico. With more than 20,000 employees serving approximately 70,000 patients daily, Acadia is the largest stand-alone behavioral health company in the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.

Contacts

Gretchen Hommrich
Director, Investor Relations
(615) 861-6000

Acadia Healthcare Company, Inc.

NASDAQ:ACHC

Release Versions

Contacts

Gretchen Hommrich
Director, Investor Relations
(615) 861-6000

More News From Acadia Healthcare Company, Inc.

Acadia Healthcare Announces Fourth Quarter and 2025 Results

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Results Revenue totaled $821.5 million, a 6.1% increase compared with the fourth quarter of 2024, supporting full-year revenue results above the Company’s previously issued guidance range Same facility revenue increased 4.4% compared with the fourth quarter of 2024, including an...

Acadia Healthcare to Participate in March Investor Conferences

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in three investor conferences in March. On Monday, March 2, 2026, the Company will participate in the Raymond James & Associates’ 47th Annual Institutional Investors Conference, being held March 1-4, 2026, in Orlando, Florida. The Company’s presentation/fireside chat will begin at 11:35 a.m. Eastern Time/10:35 a.m. Central Time. On Monday, March 9, 2026, the Com...

Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2025 Earnings Release

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its fourth quarter and year-end 2025 results on Wednesday, February 25, 2026, before the market opens. Acadia will also conduct a conference call with institutional investors and analysts on Wednesday, February 25, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website. The webcast of...
Back to Newsroom